Industry Research Reports

Home > Reports > Service & Software > Global AI In Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global AI In Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-03-12

Pages: 98 Pages

Report ld: 6238102

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

AI In Drug Development Market Size(US$)

CAGR 2026-2032

56.0%

Market Size,2032

USD 12,590

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 873 million

Market Forecast in 2032(Value)

US$ 12,590 million

CAGR

56.0%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global AI In Drug Development market size was US$ 581 million in 2025 and is forecast to reach a readjusted size of US$ 12590 million by 2032 with a CAGR of 56.0% during the forecast period 2026-2032.

AI in drug development, also known as AI-assisted drug discovery and development, refers to the application of artificial intelligence (AI) technologies, including machine learning, deep learning, natural language processing, and big data analytics, to accelerate and optimize various stages of drug research and development. This encompasses a wide range of complex and time-consuming processes, from disease target identification, drug molecule design and optimization, high-throughput screening, and preclinical research, to clinical trial design and management, and drug repurposing. By analyzing vast amounts of biomedical data, chemical structure data, genomic data, and clinical trial data, AI can uncover patterns and correlations that are difficult to detect through traditional methods, thereby enhancing the efficiency of drug discovery, reducing research and development costs, shortening time-to-market for new drugs, and improving the overall success rate of drug development.

In 2025, the North America AI In Drug Development market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

The global key players of AI In Drug Development include Pfizer, AstraZeneca, Johnson & Johnson, Novartis, Sanofi, Roche, Insilico Medicine, Exscientia, BenevolentAI, Recursion Pharmaceuticals, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global AI In Drug Development market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Pfizer
AstraZeneca
Johnson & Johnson
Novartis
Sanofi
Roche
Insilico Medicine
Exscientia
BenevolentAI
Recursion Pharmaceuticals
Atomwise
Isomorphic Labs
XtalPi
Deep Genomics
Relay Therapeutics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Software
Services

Segment by Application

Biopharmaceuticals
Synthetic Pharmaceuticals
Others

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the AI In Drug Development value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Software

1.2.3 Services

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Biopharmaceuticals

1.3.3 Synthetic Pharmaceuticals

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI In Drug Development Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global AI In Drug Development Market Share by Revenue, by Region (2021-2026)

2.4 Global AI In Drug Development Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America AI In Drug Development Market Size and Prospective (2021-2032)

2.5.2 Europe AI In Drug Development Market Size and Prospective (2021-2032)

2.5.3 China AI In Drug Development Market Size and Prospective (2021-2032)

2.5.4 Japan AI In Drug Development Market Size and Prospective (2021-2032)

2.5.5 Southeast Asia AI In Drug Development Market Size and Prospective (2021-2032)

2.5.6 India AI In Drug Development Market Size and Prospective (2021-2032)

2.5.7 South America AI In Drug Development Market Size and Prospective (2021-2032)

2.5.8 Middle East AI In Drug Development Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global AI In Drug Development Historical Market Size by Type (2021-2026)

3.2 Global AI In Drug Development Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of AI In Drug Development

4 Breakdown Data by Application

4.1 Global AI In Drug Development Historical Market Size by Application (2021-2026)

4.2 Global AI In Drug Development Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in AI In Drug Development Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top AI In Drug Development Players by Revenue (2021-2026)

5.1.2 Global AI In Drug Development Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by AI In Drug Development Revenue

5.4 Global AI In Drug Development Market Concentration Analysis

5.4.1 Global AI In Drug Development Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by AI In Drug Development Revenue in 2025

5.5 Global Key Players of AI In Drug Development Head Offices and Areas Served

5.6 Global Key Players of AI In Drug Development, Product and Application

5.7 Global Key Players of AI In Drug Development, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America AI In Drug Development Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America AI In Drug Development Market Size by Type (2021-2026)

6.1.2.2 North America AI In Drug Development Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America AI In Drug Development Market Size by Application (2021-2026)

6.1.3.2 North America AI In Drug Development Market Share by Application (2021-2026)

6.1.4 North America AI In Drug Development Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe AI In Drug Development Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe AI In Drug Development Market Size by Type (2021-2026)

6.2.2.2 Europe AI In Drug Development Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe AI In Drug Development Market Size by Application (2021-2026)

6.2.3.2 Europe AI In Drug Development Market Share by Application (2021-2026)

6.2.4 Europe AI In Drug Development Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China AI In Drug Development Revenue by Company (2021-2026)

6.3.2 China Market Size by Type

6.3.2.1 China AI In Drug Development Market Size by Type (2021-2026)

6.3.2.2 China AI In Drug Development Market Share by Type (2021-2026)

6.3.3 China Market Size by Application

6.3.3.1 China AI In Drug Development Market Size by Application (2021-2026)

6.3.3.2 China AI In Drug Development Market Share by Application (2021-2026)

6.3.4 China AI In Drug Development Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan AI In Drug Development Revenue by Company (2021-2026)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan AI In Drug Development Market Size by Type (2021-2026)

6.4.2.2 Japan AI In Drug Development Market Share by Type (2021-2026)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan AI In Drug Development Market Size by Application (2021-2026)

6.4.3.2 Japan AI In Drug Development Market Share by Application (2021-2026)

6.4.4 Japan AI In Drug Development Major Customers

6.4.5 Japan Market Trends and Opportunities

6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers

6.5.1 Southeast Asia AI In Drug Development Revenue by Company (2021-2026)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia AI In Drug Development Market Size by Type (2021-2026)

6.5.2.2 Southeast Asia AI In Drug Development Market Share by Type (2021-2026)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia AI In Drug Development Market Size by Application (2021-2026)

6.5.3.2 Southeast Asia AI In Drug Development Market Share by Application (2021-2026)

6.5.4 Southeast Asia AI In Drug Development Major Customers

6.5.5 Southeast Asia Market Trends and Opportunities

6.6 India Market: Players, Segments, Downstream and Major Customers

6.6.1 India AI In Drug Development Revenue by Company (2021-2026)

6.6.2 India Market Size by Type

6.6.2.1 India AI In Drug Development Market Size by Type (2021-2026)

6.6.2.2 India AI In Drug Development Market Share by Type (2021-2026)

6.6.3 India Market Size by Application

6.6.3.1 India AI In Drug Development Market Size by Application (2021-2026)

6.6.3.2 India AI In Drug Development Market Share by Application (2021-2026)

6.6.4 India AI In Drug Development Major Customers

6.6.5 India Market Trends and Opportunities

7 Key Player Profiles

7.1 Pfizer

7.1.1 Pfizer Company Details

7.1.2 Pfizer Business Overview

7.1.3 Pfizer AI In Drug Development Introduction

7.1.4 Pfizer Revenue in AI In Drug Development Business (2021-2026)

7.1.5 Pfizer Recent Development

7.2 AstraZeneca

7.2.1 AstraZeneca Company Details

7.2.2 AstraZeneca Business Overview

7.2.3 AstraZeneca AI In Drug Development Introduction

7.2.4 AstraZeneca Revenue in AI In Drug Development Business (2021-2026)

7.2.5 AstraZeneca Recent Development

7.3 Johnson & Johnson

7.3.1 Johnson & Johnson Company Details

7.3.2 Johnson & Johnson Business Overview

7.3.3 Johnson & Johnson AI In Drug Development Introduction

7.3.4 Johnson & Johnson Revenue in AI In Drug Development Business (2021-2026)

7.3.5 Johnson & Johnson Recent Development

7.4 Novartis

7.4.1 Novartis Company Details

7.4.2 Novartis Business Overview

7.4.3 Novartis AI In Drug Development Introduction

7.4.4 Novartis Revenue in AI In Drug Development Business (2021-2026)

7.4.5 Novartis Recent Development

7.5 Sanofi

7.5.1 Sanofi Company Details

7.5.2 Sanofi Business Overview

7.5.3 Sanofi AI In Drug Development Introduction

7.5.4 Sanofi Revenue in AI In Drug Development Business (2021-2026)

7.5.5 Sanofi Recent Development

7.6 Roche

7.6.1 Roche Company Details

7.6.2 Roche Business Overview

7.6.3 Roche AI In Drug Development Introduction

7.6.4 Roche Revenue in AI In Drug Development Business (2021-2026)

7.6.5 Roche Recent Development

7.7 Insilico Medicine

7.7.1 Insilico Medicine Company Details

7.7.2 Insilico Medicine Business Overview

7.7.3 Insilico Medicine AI In Drug Development Introduction

7.7.4 Insilico Medicine Revenue in AI In Drug Development Business (2021-2026)

7.7.5 Insilico Medicine Recent Development

7.8 Exscientia

7.8.1 Exscientia Company Details

7.8.2 Exscientia Business Overview

7.8.3 Exscientia AI In Drug Development Introduction

7.8.4 Exscientia Revenue in AI In Drug Development Business (2021-2026)

7.8.5 Exscientia Recent Development

7.9 BenevolentAI

7.9.1 BenevolentAI Company Details

7.9.2 BenevolentAI Business Overview

7.9.3 BenevolentAI AI In Drug Development Introduction

7.9.4 BenevolentAI Revenue in AI In Drug Development Business (2021-2026)

7.9.5 BenevolentAI Recent Development

7.10 Recursion Pharmaceuticals

7.10.1 Recursion Pharmaceuticals Company Details

7.10.2 Recursion Pharmaceuticals Business Overview

7.10.3 Recursion Pharmaceuticals AI In Drug Development Introduction

7.10.4 Recursion Pharmaceuticals Revenue in AI In Drug Development Business (2021-2026)

7.10.5 Recursion Pharmaceuticals Recent Development

7.11 Atomwise

7.11.1 Atomwise Company Details

7.11.2 Atomwise Business Overview

7.11.3 Atomwise AI In Drug Development Introduction

7.11.4 Atomwise Revenue in AI In Drug Development Business (2021-2026)

7.11.5 Atomwise Recent Development

7.12 Isomorphic Labs

7.12.1 Isomorphic Labs Company Details

7.12.2 Isomorphic Labs Business Overview

7.12.3 Isomorphic Labs AI In Drug Development Introduction

7.12.4 Isomorphic Labs Revenue in AI In Drug Development Business (2021-2026)

7.12.5 Isomorphic Labs Recent Development

7.13 XtalPi

7.13.1 XtalPi Company Details

7.13.2 XtalPi Business Overview

7.13.3 XtalPi AI In Drug Development Introduction

7.13.4 XtalPi Revenue in AI In Drug Development Business (2021-2026)

7.13.5 XtalPi Recent Development

7.14 Deep Genomics

7.14.1 Deep Genomics Company Details

7.14.2 Deep Genomics Business Overview

7.14.3 Deep Genomics AI In Drug Development Introduction

7.14.4 Deep Genomics Revenue in AI In Drug Development Business (2021-2026)

7.14.5 Deep Genomics Recent Development

7.15 Relay Therapeutics

7.15.1 Relay Therapeutics Company Details

7.15.2 Relay Therapeutics Business Overview

7.15.3 Relay Therapeutics AI In Drug Development Introduction

7.15.4 Relay Therapeutics Revenue in AI In Drug Development Business (2021-2026)

7.15.5 Relay Therapeutics Recent Development

8 AI In Drug Development Market Dynamics

8.1 AI In Drug Development Industry Trends

8.2 AI In Drug Development Market Drivers

8.3 AI In Drug Development Market Challenges

8.4 AI In Drug Development Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global AI In Drug Development Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global AI In Drug Development Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market AI In Drug Development Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global AI In Drug Development Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global AI In Drug Development Revenue Share by Region (2021-2026)

Table 6. Global AI In Drug Development Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global AI In Drug Development Revenue Share Forecast by Region (2027-2032)

Table 8. Global AI In Drug Development Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global AI In Drug Development Market Share by Revenue, by Type (2021-2026)

Table 10. Global AI In Drug Development Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global AI In Drug Development Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global AI In Drug Development Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global AI In Drug Development Market Share by Revenue, by Application (2021-2026)

Table 15. Global AI In Drug Development Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global AI In Drug Development Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in AI In Drug Development Applications

Table 18. Global AI In Drug Development Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global AI In Drug Development Market Share by Players (2021-2026)

Table 20. Global Top AI In Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Drug Development as of 2025)

Table 21. Ranking of Global Top AI In Drug Development Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by AI In Drug Development Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of AI In Drug Development, Headquarters and Area Served

Table 24. Global Key Players of AI In Drug Development, Product and Application

Table 25. Global Key Players of AI In Drug Development, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America AI In Drug Development Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America AI In Drug Development Market Share by Revenue, by Company (2021-2026)

Table 29. North America AI In Drug Development Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America AI In Drug Development Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe AI In Drug Development Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe AI In Drug Development Market Share by Revenue, by Company (2021-2026)

Table 33. Europe AI In Drug Development Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe AI In Drug Development Market Size by Application (2021-2026) & (US$ Million)

Table 35. China AI In Drug Development Revenue by Company (2021-2026) & (US$ Million)

Table 36. China AI In Drug Development Market Share by Revenue, by Company (2021-2026)

Table 37. China AI In Drug Development Market Size by Type (2021-2026) & (US$ Million)

Table 38. China AI In Drug Development Market Size by Application (2021-2026) & (US$ Million)

Table 39. Japan AI In Drug Development Revenue by Company (2021-2026) & (US$ Million)

Table 40. Japan AI In Drug Development Market Share by Revenue, by Company (2021-2026)

Table 41. Japan AI In Drug Development Market Size by Type (2021-2026) & (US$ Million)

Table 42. Japan AI In Drug Development Market Size by Application (2021-2026) & (US$ Million)

Table 43. Southeast Asia AI In Drug Development Revenue by Company (2021-2026) & (US$ Million)

Table 44. Southeast Asia AI In Drug Development Market Share by Revenue, by Company (2021-2026)

Table 45. Southeast Asia AI In Drug Development Market Size by Type (2021-2026) & (US$ Million)

Table 46. Southeast Asia AI In Drug Development Market Size by Application (2021-2026) & (US$ Million)

Table 47. India AI In Drug Development Revenue by Company (2021-2026) & (US$ Million)

Table 48. India AI In Drug Development Market Share by Revenue, by Company (2021-2026)

Table 49. India AI In Drug Development Market Size by Type (2021-2026) & (US$ Million)

Table 50. India AI In Drug Development Market Size by Application (2021-2026) & (US$ Million)

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer AI In Drug Development Product

Table 54. Pfizer Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. AstraZeneca Company Details

Table 57. AstraZeneca Business Overview

Table 58. AstraZeneca AI In Drug Development Product

Table 59. AstraZeneca Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 60. AstraZeneca Recent Development

Table 61. Johnson & Johnson Company Details

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson AI In Drug Development Product

Table 64. Johnson & Johnson Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 65. Johnson & Johnson Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis AI In Drug Development Product

Table 69. Novartis Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. Sanofi Company Details

Table 72. Sanofi Business Overview

Table 73. Sanofi AI In Drug Development Product

Table 74. Sanofi Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 75. Sanofi Recent Development

Table 76. Roche Company Details

Table 77. Roche Business Overview

Table 78. Roche AI In Drug Development Product

Table 79. Roche Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 80. Roche Recent Development

Table 81. Insilico Medicine Company Details

Table 82. Insilico Medicine Business Overview

Table 83. Insilico Medicine AI In Drug Development Product

Table 84. Insilico Medicine Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 85. Insilico Medicine Recent Development

Table 86. Exscientia Company Details

Table 87. Exscientia Business Overview

Table 88. Exscientia AI In Drug Development Product

Table 89. Exscientia Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 90. Exscientia Recent Development

Table 91. BenevolentAI Company Details

Table 92. BenevolentAI Business Overview

Table 93. BenevolentAI AI In Drug Development Product

Table 94. BenevolentAI Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 95. BenevolentAI Recent Development

Table 96. Recursion Pharmaceuticals Company Details

Table 97. Recursion Pharmaceuticals Business Overview

Table 98. Recursion Pharmaceuticals AI In Drug Development Product

Table 99. Recursion Pharmaceuticals Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 100. Recursion Pharmaceuticals Recent Development

Table 101. Atomwise Company Details

Table 102. Atomwise Business Overview

Table 103. Atomwise AI In Drug Development Product

Table 104. Atomwise Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 105. Atomwise Recent Development

Table 106. Isomorphic Labs Company Details

Table 107. Isomorphic Labs Business Overview

Table 108. Isomorphic Labs AI In Drug Development Product

Table 109. Isomorphic Labs Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 110. Isomorphic Labs Recent Development

Table 111. XtalPi Company Details

Table 112. XtalPi Business Overview

Table 113. XtalPi AI In Drug Development Product

Table 114. XtalPi Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 115. XtalPi Recent Development

Table 116. Deep Genomics Company Details

Table 117. Deep Genomics Business Overview

Table 118. Deep Genomics AI In Drug Development Product

Table 119. Deep Genomics Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 120. Deep Genomics Recent Development

Table 121. Relay Therapeutics Company Details

Table 122. Relay Therapeutics Business Overview

Table 123. Relay Therapeutics AI In Drug Development Product

Table 124. Relay Therapeutics Revenue in AI In Drug Development Business (2021-2026) & (US$ Million)

Table 125. Relay Therapeutics Recent Development

Table 126. AI In Drug Development Market Trends

Table 127. AI In Drug Development Market Drivers

Table 128. AI In Drug Development Market Challenges

Table 129. AI In Drug Development Market Restraints

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. AI In Drug Development Product Picture

Figure 2. Global AI In Drug Development Market Share by Type: 2025 vs 2032

Figure 3. Software Features

Figure 4. Services Features

Figure 5. Global AI In Drug Development Market Share by Application: 2025 vs 2032

Figure 6. Biopharmaceuticals

Figure 7. Synthetic Pharmaceuticals

Figure 8. Others

Figure 9. AI In Drug Development Report Years Considered

Figure 10. Global AI In Drug Development Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 11. Global AI In Drug Development Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global AI In Drug Development Market Share by Revenue, by Region: 2021 vs 2025

Figure 13. North America AI In Drug Development Revenue (US$ Million) Growth Rate (2021-2032)

Figure 14. Europe AI In Drug Development Revenue (US$ Million) Growth Rate (2021-2032)

Figure 15. China AI In Drug Development Revenue (US$ Million) Growth Rate (2021-2032)

Figure 16. Japan AI In Drug Development Revenue (US$ Million) Growth Rate (2021-2032)

Figure 17. Southeast Asia AI In Drug Development Revenue (US$ Million) Growth Rate (2021-2032)

Figure 18. India AI In Drug Development Revenue (US$ Million) Growth Rate (2021-2032)

Figure 19. South America AI In Drug Development Revenue (US$ Million) Growth Rate (2021-2032)

Figure 20. Middle East AI In Drug Development Revenue (US$ Million) Growth Rate (2021-2032)

Figure 21. Global AI In Drug Development Market Share by Players in 2025

Figure 22. Global Top AI In Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Drug Development as of 2025)

Figure 23. The Top 10 and 5 Players Market Share by AI In Drug Development Revenue in 2025

Figure 24. North America AI In Drug Development Market Share by Type (2021-2026)

Figure 25. North America AI In Drug Development Market Share by Application (2021-2026)

Figure 26. Europe AI In Drug Development Market Share by Type (2021-2026)

Figure 27. Europe AI In Drug Development Market Share by Application (2021-2026)

Figure 28. China AI In Drug Development Market Share by Type (2021-2026)

Figure 29. China AI In Drug Development Market Share by Application (2021-2026)

Figure 30. Japan AI In Drug Development Market Share by Type (2021-2026)

Figure 31. Japan AI In Drug Development Market Share by Application (2021-2026)

Figure 32. Southeast Asia AI In Drug Development Market Share by Type (2021-2026)

Figure 33. Southeast Asia AI In Drug Development Market Share by Application (2021-2026)

Figure 34. India AI In Drug Development Market Share by Type (2021-2026)

Figure 35. India AI In Drug Development Market Share by Application (2021-2026)

Figure 36. Pfizer Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 37. AstraZeneca Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 38. Johnson & Johnson Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 39. Novartis Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 40. Sanofi Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 41. Roche Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 42. Insilico Medicine Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 43. Exscientia Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 44. BenevolentAI Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 45. Recursion Pharmaceuticals Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 46. Atomwise Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 47. Isomorphic Labs Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 48. XtalPi Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 49. Deep Genomics Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 50. Relay Therapeutics Revenue Growth Rate in AI In Drug Development Business (2021-2026)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of AI In Drug Development in 2032? zhanKai

The global market size of AI In Drug Development in 2032 was 12590 Million USD.

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global AI In Drug Development market size from 2026 to 2032? shouQi

Which companies rank high in the global AI In Drug Development market? shouQi

What was the global market size of AI In Drug Development in 2026? shouQi

Related Reports

Global AI In Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI In Drug Development market is projected to grow from US$ 581 million in 2025 to US$ 12590 million by 2032, at a CAGR of 56.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 144
USD 4900.00
(Single User License)
Global AI In Drug Development Market Research Report 2026
The global AI In Drug Development market was valued at US$ 581 million in 2025 and is anticipated to reach US$ 12590 million by 2032, at a CAGR of 56.0% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 112
USD 2900.00
(Single User License)
AI In Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI In Drug Development was estimated to be worth US$ 581 million in 2025 and is projected to reach US$ 12590 million, growing at a CAGR of 56.0% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 108
USD 3950.00
(Single User License)
Global AI In Drug Development Market Research Report 2025
The global market for AI In Drug Development was valued at US$ 209 million in the year 2024 and is projected to reach a revised size of US$ 8369 million by 2031, growing at a CAGR of 56.0% during the forecast period.
Published Date: 2025-07-24
Pages: 87
USD 2900.00
(Single User License)
AI In Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI In Drug Development was estimated to be worth US$ 209 million in 2024 and is forecast to a readjusted size of US$ 8369 million by 2031 with a CAGR of 56.0% during the forecast period 2025-2031.
Published Date: 2025-07-24
Pages: 102
USD 3950.00
(Single User License)
Global AI In Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI In Drug Development market is projected to grow from US$ 209 million in 2024 to US$ 8369 million by 2031, at a CAGR of 56.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-24
Pages: 138
USD 4900.00
(Single User License)
Global AI In Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI In Drug Development market size was US$ 209 million in 2024 and is forecast to a readjusted size of US$ 8369 million by 2031 with a CAGR of 56.0% during the forecast period 2025-2031.
Published Date: 2025-07-24
Pages: 95
USD 4250.00
(Single User License)

Global AI In Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI In Drug Development market is projected to grow from US$ 581 million in 2025 to US$ 12590 million by 2032, at a CAGR of 56.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 144
USD 4900.00 (Single User License)
Global AI In Drug Development Market Research Report 2026
The global AI In Drug Development market was valued at US$ 581 million in 2025 and is anticipated to reach US$ 12590 million by 2032, at a CAGR of 56.0% from 2026 to 2032.
Published: 2026-03-12
Pages: 112
USD 2900.00 (Single User License)
AI In Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI In Drug Development was estimated to be worth US$ 581 million in 2025 and is projected to reach US$ 12590 million, growing at a CAGR of 56.0% from 2026 to 2032.
Published: 2026-03-09
Pages: 108
USD 3950.00 (Single User License)
Global AI In Drug Development Market Research Report 2025
The global market for AI In Drug Development was valued at US$ 209 million in the year 2024 and is projected to reach a revised size of US$ 8369 million by 2031, growing at a CAGR of 56.0% during the forecast period.
Published: 2025-07-24
Pages: 87
USD 2900.00 (Single User License)
AI In Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI In Drug Development was estimated to be worth US$ 209 million in 2024 and is forecast to a readjusted size of US$ 8369 million by 2031 with a CAGR of 56.0% during the forecast period 2025-2031.
Published: 2025-07-24
Pages: 102
USD 3950.00 (Single User License)
Global AI In Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI In Drug Development market is projected to grow from US$ 209 million in 2024 to US$ 8369 million by 2031, at a CAGR of 56.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-24
Pages: 138
USD 4900.00 (Single User License)
Global AI In Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI In Drug Development market size was US$ 209 million in 2024 and is forecast to a readjusted size of US$ 8369 million by 2031 with a CAGR of 56.0% during the forecast period 2025-2031.
Published: 2025-07-24
Pages: 95
USD 4250.00 (Single User License)